Engineering GPCR signaling pathways with RASSLs |
| |
Authors: | Conklin Bruce R Hsiao Edward C Claeysen Sylvie Dumuis Aline Srinivasan Supriya Forsayeth John R Guettier Jean-Marc Chang W C Pei Ying McCarthy Ken D Nissenson Robert A Wess Jürgen Bockaert Joël Roth Bryan L |
| |
Institution: | Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, California 94158, USA. bconklin@gladstone.ucsf.edu |
| |
Abstract: | We are creating families of designer G protein-coupled receptors (GPCRs) to allow for precise spatiotemporal control of GPCR signaling in vivo. These engineered GPCRs, called receptors activated solely by synthetic ligands (RASSLs), are unresponsive to endogenous ligands but can be activated by nanomolar concentrations of pharmacologically inert, drug-like small molecules. Currently, RASSLs exist for the three major GPCR signaling pathways (G(s), G(i) and G(q)). We review these advances here to facilitate the use of these powerful and diverse tools. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|